flurandrenolide

Generic: FLURANDRENOLIDE·Brand: CORDRAN, CORDRAN SP, Cordran, FLURANDRENOLIDE, Nolix

flurandrenolide: developed by 1 company · 1 FDA decision.

What we can confirm

1 FDA record

Teligent, Inc. (TLGT)

What it means

Source-backed records connect flurandrenolide to TLGT; that link alone does not prove the drug works.

What to watch

Watch for new trials or company disclosures after the FDA record.

BioSniper AIPage evidence connected

Prepared research question

How could flurandrenolide → TLGT affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

Development Pipeline (1)

Company	Phase	Indication
Teligent, Inc. (TLGT)	Approved	—

FDA Decisions1 records

ApprovalINDICATIONS AND USAGE Flurandrenolide Lotion USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.(TLGT)FDA ↗

Dec 30, 2016

ANDA207851UNKNOWNStandardTopicalOintment

Frequently asked questions

Who is developing flurandrenolide?

flurandrenolide is being developed by Teligent, Inc..

What is flurandrenolide's latest FDA decision?

The most recent tracked FDA decision for flurandrenolide is Approval for INDICATIONS AND USAGE Flurandrenolide Lotion USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses., dated December 30, 2016.